MedPath

NEOMEDLIGHT

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of CareMin650 for Prevention of Oral Mucositis in HNC Patients Starting Radiotherapy

Not Applicable
Completed
Conditions
Head and Neck Cancer
Oral Mucositis (Ulcerative) Due to Radiation
Radiation Therapy Complication
Interventions
Device: Photobiomodulation
First Posted Date
2021-01-07
Last Posted Date
2022-10-10
Lead Sponsor
NeoMedLight
Target Recruit Count
15
Registration Number
NCT04699487
Locations
🇩🇪

UNIKLINIK RWTH AACHEN - Klinik für Radioonkologie und Strahlentherapie, Aachen, Germany

Feasibility and Safety of CareMin650 in Patients at Risk of or Suffering From Oral Mucositis and/or Radiation Dermatitis

Not Applicable
Completed
Conditions
Radiation Dermatitis
Oral Mucositis Due to Radiation
Interventions
Device: Photobiomodulation using CareMin650 at 3 Joules (prophylactic intent)
Device: Photobiomodulation using CareMin650 at 6 Joules (curative intent)
First Posted Date
2019-06-17
Last Posted Date
2021-04-30
Lead Sponsor
NeoMedLight
Target Recruit Count
72
Registration Number
NCT03988556
Locations
🇫🇷

Centre de Haute Energie, Nice, France

🇫🇷

Institut Curie, Paris, France

🇫🇷

Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath